Pharming Group N.V.

Symbol: PHARM.AS

EURONEXT

0.873

EUR

Market price today

  • -60.2406

    P/E Ratio

  • -73.5675

    PEG Ratio

  • 587.91M

    MRK Cap

  • 0.00%

    DIV Yield

Pharming Group N.V. (PHARM-AS) Stock Split, History Data

Working capital analysis

In terms of working capital, Pharming Group N.V. maintains a healthy position. The total current assets of the company are valued at $286373059. This represents a growth rate of 3.197% compared to the previous year. Breaking down the current assets, the cash and investments are worth $55891911, exhibiting a growth rate of -73.044% year-on-year. The receivables, another significant portion of the current assets, are valued at $38577830. The year-on-year growth rate for receivables is 39.679%. The inventory, which forms a critical part of the assets, is valued at $51382790. This represents a healthy year-on-year growth of 21.398% On the liabilities side, the company's current liabilities total $70581632. This reflects a growth rate of 18.231% over the previous year, indicating the company's financial obligations are well under control.

202320222021202020192018
Cash and investments
55.89
207.34
191.72
205.49
74.27
91.87
Receavebles
38.58
27.62
29.95
31.94
26.28
18.30
Inventory
51.38
42.33
27.28
21.19
16.21
19.81
Other
3.21
0.21
0.23
5.02
2.55
1.81
Total Current Assets
286.37
277.50
249.18
263.63
119.30
132.05
Acc Payable
14.50
54.47
42.43
13.49
5.99
7.60
Short Term Debt
4.92
5.23
4.29
4.01
53.25
40.61
Other Current Liab
51.15
42.83
30.67
25.22
20.28
45.37
Current Liabilities
70.58
59.70
46.72
76.97
114.13
94.49

Capital Structure

When examining the capital structure of Pharming Group N.V., it is clear that the company manages a robust portfolio. These earnings represent the profits that Pharming Group N.V. has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$NaN

Total liabilities

$NaN

Long term debt

$NaN

Cash and eqv

$NaN

Goodwill

$NaN

Retained earnings

$NaN

Common stock

$NaN

Enterprise Value

$53.06

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is -0.028.

What is company revenue per share?

The company revenue per share is -0.022.

What are firm earnings per share?

The firm earnings per share is 0.878.

What is Pharming Group N.V. (PHARM.AS) ROIC (return on capital)?

Pharming Group N.V. (PHARM.AS) ROIC (return on capital) is -0.014.

What is dividend per share figure?

The dividend per share is 0.000

What is enterprise plowback ratio?

Pharming Group N.V. (PHARM.AS) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 53.058

What is company debt to equity ratio?

The debt to equity ratio is 0.784

What are debt ratio numbers?

The debt ratio is 0.371

What is company price to sales ratio?

The price to sales ratio is 2.584